Who Exports Pyrimethamine from India — 70 Suppliers Behind a $46.4M Market
India's pyrimethamine export market is supplied by 70 active exporters who collectively shipped $46.4M across 411 shipments. S KANT HEALTHCARE LIMITED leads with a 58.2% market share, followed by MACLEODS PHARMACEUTICALS LTD and IPCA LABORATORIES LIMITED. The top 5 suppliers together control 83.2% of total export value, reflecting a concentrated market structure.
Top Pyrimethamine Exporters from India — Ranked by Export Value
S KANT HEALTHCARE LIMITED is the leading pyrimethamine exporter from India, holding a 58.2% share of the $46.4M market across 411 shipments from 70 exporters. The top 5 suppliers — S KANT HEALTHCARE LIMITED, MACLEODS PHARMACEUTICALS LTD, IPCA LABORATORIES LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED, MEDOPHARM — collectively control 83.2% of total export value, indicating a highly concentrated market. Individual shares are: S KANT HEALTHCARE LIMITED (58.2%), MACLEODS PHARMACEUTICALS LTD (8.6%), IPCA LABORATORIES LIMITED (8.4%), FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED (4.1%), MEDOPHARM (3.9%).
Top Pyrimethamine Exporters from India
Ranked by export value · 70 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | S KANT HEALTHCARE LIMITED LARIDOXSULPHADOXINE 500MG + PYRIMETHAMINE 25MGSULFADOXINE AND PYRIMETHAMINE TABLETS US | $27.0M | 17 | 58.2% |
| 2 | MACLEODS PHARMACEUTICALS LTD LARIDOXSULFADOXINE & PYRIMETHAMINE TABLETS USP( | $4.0M | 12 | 8.6% |
| 3 | IPCA LABORATORIES LIMITED LARIDOXSULFADOXINE & PYRIMETHAMINE TABLETS USP(SULFADOXINE 500 MG + PYRIMETHAMINE 25 MG | $3.9M | 2 | 8.4% |
| 4 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED SULPHADOXINE 500MG + PYRIMETHAMINE 25MGSULFADOXINE AND PYRIMETHAMINE TABLETS USSULPHADOXINE & PYRIMETHAMINE TABLETS USP | $1.9M | 4 | 4.1% |
| 5 | MEDOPHARM SULFADOXINE AND PYRIMETHAMINE TABLETS USSULPHADOXINE & PYRIMETHAMINE TABLETS USP | $1.8M | 4 | 3.9% |
| 6 | APL HEALTHCARE LIMITED | $1.4M | 1 | 3.0% |
| 7 | S K AGE EXPORTS LARIDOXSULPHADOXINE 500MG + PYRIMETHAMINE 25MGSULFADOXINE AND PYRIMETHAMINE TABLETS US | $1.1M | 3 | 2.4% |
| 8 | GRACURE PHARMACEUTICALS LIMITED | $818.5K | 1 | 1.8% |
| 9 | SHALINA LABORATORIES PRIVATE LIMITED SULFADOXINE AND PYRIMETHAMINE TABLETS USSULPHADOXINE & PYRIMETHAMINE TABLETS USP | $574.8K | 9 | 1.2% |
| 10 | MEDOPHARM PRIVATE LIMITED SULFADOXINE AND PYRIMETHAMINE TABLETS USSULPHADOXINE & PYRIMETHAMINE TABLETS USP | $262.7K | 1 | 0.6% |
| 11 | MEPRO PHARMACEUTICALS PRIVATE LIMITED | $262.4K | 4 | 0.6% |
| 12 | INTERMED LABORATORIES PRIVATE LIMITED | $188.6K | 1 | 0.4% |
| 13 | SHALINA LABORATORIES PVT LTD SULFADOXINE AND PYRIMETHAMINE TABLETS USSULPHADOXINE & PYRIMETHAMINE TABLETS USP | $170.2K | 3 | 0.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Pyrimethamine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| S KANT HEALTHCARE LIMITED | Not Listed | Yes, as of May 2, 20 | No | Not verified | WHO prequalified Pyrimethamine/Sulfadoxine tablets on May 2, 2024. (extranet.who |
| MACLEODS PHARMACEUTICALS LTD | Not Listed | Yes, as of May 29, 2 | Yes | Not verified | WHO prequalified Artesunate powder for injection on May 29, 2024; EU GMP certifi |
| IPCA LABORATORIES LIMITED | Warning Letter, December | Yes, as of April 25, | No | Not verified | WHO prequalified Pyrimethamine/Sulfadoxine tablets on April 25, 2024; FDA issued |
| FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | Not Listed | Yes | No | Not verified | WHO-GMP certified by CDSCO. |
| MEDOPHARM PRIVATE LIMITED | Not Listed | Yes | Yes, as of June | Not verified | WHO-GMP certified by CDSCO; EU GMP certified as of June 10, 2024. |
| S K AGE EXPORTS | Not Listed | No | No | Not verified | No certifications found. |
| GRACURE PHARMACEUTICALS LIMITED | Not Listed | No | No | Not verified | No certifications found. |
| SHALINA LABORATORIES PRIVATE LIMITED | Not Listed | No | No | Not verified | No certifications found. |
| MEPRO PHARMACEUTICALS PRIVATE LIMITED | Not Listed | No | No | Not verified | No certifications found. |
| INTERMED LABORATORIES PRIVATE LIMITED | Not Listed | No | No | Not verified | No certifications found. |
TransData Nexus reviewed the regulatory standing of 10 leading Pyrimethamine exporters from India. 0 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Pyrimethamine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of Active Pharmaceutical Ingredients (APIs). The city's pharmaceutical landscape is characterized by a robust infrastructure, a skilled workforce, and a favorable regulatory environment, making it a pivotal hub for API manufacturing. Companies in Hyderabad are well-positioned to supply high-quality APIs, including Pyrimethamine, to both domestic and international markets.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent center for pharmaceutical formulations. This region hosts numerous manufacturing units specializing in the production of finished dosage forms. Notably, Taj Pharmaceuticals, headquartered in Vapi, Gujarat, is recognized for manufacturing Pyrimethamine Tablets USP 25 mg, adhering to stringent quality standards and serving a global clientele.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. This region's proximity to major ports facilitates efficient international distribution. Companies operating here benefit from well-established logistics networks, enabling them to export pharmaceuticals, including Pyrimethamine, to various global markets.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical hub, largely due to favorable tax incentives and supportive government policies. Baddi, in particular, is home to numerous pharmaceutical companies, contributing substantially to India's pharmaceutical output.
5Sourcing Recommendations
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and quality standards of suppliers in Hyderabad for API procurement and in the Ahmedabad-Vadodara region for finished formulations.
- Leverage Export Infrastructure: Utilize the logistical advantages of the Mumbai-Thane-Raigad region to streamline the export process of Pyrimethamine products.
- Consider Cost Benefits: Explore manufacturing options in the Baddi-Nalagarh region to potentially benefit from tax incentives and cost efficiencies.
- Ensure Regulatory Compliance: Verify that all suppliers adhere to international regulatory standards to maintain product quality and facilitate global market access.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can optimize its supply chain for Pyrimethamine, ensuring quality, cost-effectiveness, and efficient distribution.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Pyrimethamine exporters from India
Ipca Laboratories Limited — Ipca Laboratories acquires 33.38% stake in Unichem Laboratories
Ipca Laboratories entered into a definitive Share Purchase Agreement to acquire 2,35,01,440 fully paid-up equity shares of Unichem Laboratories Ltd., constituting 33.38% of its paid-up equity share capital, for ₹1,034.06 crore. - IMPACT: This acquisition is expected to enhance Ipca's manufacturing capabilities, potentially increasing Pyrimethamine production and export capacity.
Impact: This acquisition is expected to enhance Ipca's manufacturing capabilities, potentially increasing Pyrimethamine production and export capacity.
Macleods Pharmaceuticals Ltd. — Macleods Pharmaceuticals receives approval for new manufacturing facility
Macleods Pharmaceuticals Ltd. received regulatory approval for a new manufacturing facility, enhancing its production capacity for various pharmaceutical products. - IMPACT: The increased production capacity may lead to higher Pyrimethamine output, strengthening export capabilities.
Impact: The increased production capacity may lead to higher Pyrimethamine output, strengthening export capabilities.
Ipca Laboratories Limited — Ipca Laboratories invests in Unichem Laboratories
Ipca Laboratories invested in Unichem Laboratories, aiming to strengthen its position in the pharmaceutical contract manufacturing industry. - IMPACT: This investment is likely to bolster Ipca's production capabilities, potentially increasing Pyrimethamine exports.
Impact: This investment is likely to bolster Ipca's production capabilities, potentially increasing Pyrimethamine exports.
Common Questions — Pyrimethamine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which pyrimethamine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, S KANT HEALTHCARE LIMITED leads with 85 recorded shipments worth $27.0M. MACLEODS PHARMACEUTICALS LTD (34 shipments) and IPCA LABORATORIES LIMITED (3 shipments) are also established high-volume exporters.
Q How many pyrimethamine manufacturers are there in India?
India has 70 active pyrimethamine exporters with a combined export market of $46.4M across 411 shipments to 46 countries. The top 5 suppliers hold 83.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for pyrimethamine from India?
Average FOB unit price: $41.21 per unit, ranging from $0.01 to $2941.61. Average shipment value: $112.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 70 verified Indian exporters of Pyrimethamine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 411 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 46 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
411 Verified Shipments
70 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists